Navigation Links
Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
Date:3/14/2008

acne and burns.

About Isolagen, Inc.

Isolagen(TM), Inc. (Amex: ILE) is an aesthetic and therapeutic company committed to developing and commercializing scientific advances and innovative technologies. The company's technology platform includes the Isolagen Process(TM), a cell processing system for skin and tissue rejuvenation which is currently in clinical development for a broad range of aesthetic and therapeutic applications including wrinkles, acne scars, burns and periodontal disease. Isolagen also commercializes a scientifically-advanced line of skincare systems through its majority-owned subsidiary, Agera(R) Laboratories, Inc. For additional information, please visit http://www.isolagen.com .

Isolagen Forward Looking Statements

All statements in this news release that are not based on historical fact are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release, include, without limitation, the timely completion of the study injections, the timely completion of the overall acne study, the timely completion of the Company's Phase III wrinkle study, and the Company's ability to raise additional funding, whether through strategic partners for outlicensing, by selling its Swiss facility, or otherwise. While management has based any forward-looking statements contained herein on its current expectations, the information on which such expectations were based may change. These forward- looking statements rely on a number of assumpti
'/>"/>

SOURCE Isolagen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones
2. Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)
3. MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study
4. Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501
5. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
6. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
7. Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity
8. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
9. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
10. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
11. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... WASHINGTON, Dec. 14 Following is a ... the Consumer Healthcare Products Association (CHPA), regarding today,s ... (NIDA,s) Monitoring the Future survey: ,, "Findings released ... speak to the need for continued efforts to ... need to talk to their teens about medicine ...
(Date:12/14/2009)... Perry Baromedical, international leader in Hyperbaric Chamber manufacturing ... Sigma Elite, with extended patient data capture capability. ... available on each monoplace chamber model currently available ... ,, The Sigma Elite New "Smart Hyperbaric System" ... for Each Dive Electronic (EMR) Medical ...
(Date:12/14/2009)... Zargis Medical Corp., a majority-owned subsidiary ... a spin-off from Siemens Corporate Research (NYSE: ... begun selling its award-winning Zargis Cardioscan(TM) system on ... its accompanying Bluetooth®-enabled electronic stethoscope were jointly named ... Innovation of the Year." Cardioscan is the ...
Breaking Medicine Technology:Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 3Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability 2Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com 2Masimo to Present at the 21st Annual Piper Jaffray Health Care Conference 61796 1Masimo to Present at the 21st Annual Piper Jaffray Health Care Conference 61796 2Experts Examine Possible Links Between Climate Change and Infectious Disease Transmission 61793 1Experts Examine Possible Links Between Climate Change and Infectious Disease Transmission 61793 2Experts Examine Possible Links Between Climate Change and Infectious Disease Transmission 61793 3Smith 26amp 3B Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 6427 1Smith 26amp 3B Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 6427 2Smith 26amp 3B Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 6427 3Smith 26amp 3B Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 6427 4
... (Nasdaq: GNTA ) announced today that the ... of Genta,s appeal of the non-,approvable decision for ... use,of Genasense(R) (oblimersen sodium injection) plus chemotherapy in ... Company had,previously provided guidance that a final decision ...
... SKILLMAN, N.J., Jan. 11 According to the ... world,s population,suffers from eczema, an inflamed skin condition ... manage the condition,s symptoms, which tend to,flare up ... ACTIVE NATURALS(R),has introduced the Eczema Care Moisturizing Cream ...
Other Medicine Technology:FDA Extends Review of Genasense(R) NDA Appeal in Chronic Lymphocytic Leukemia 2FDA Extends Review of Genasense(R) NDA Appeal in Chronic Lymphocytic Leukemia 3New AVEENO(R) Eczema Care Product Line Offers Breakthrough Formulas to Help Manage the Signs and Symptoms of Eczema 2
(Date:12/14/2009)... UC San Diego School of Medicine and Osaka University ... prevent liver damage, including inflammation, fibrosis and cancer. The ... protein, TAK1, works could lead to new insights into ... "TAK1 appears to be a master regulator of liver ... and Dean of the UC San Diego School of ...
(Date:12/14/2009)... cites lower rates for meth and smoking, but ... 14 (HealthDay News) -- Fewer teenagers are using ... and abuse of prescription drugs remains high, U.S. ... that newer drugs, such as the hallucinogenic salvia ... intended for treatment of attention-deficit hyperactivity disorder (ADHD), ...
(Date:12/14/2009)... -- Concetta F. Conkling of Moraga, CA, retired Senior ... been elected Chair of the Board of Trustees of ... nearly 90-year-old organization to which Helen Keller devoted more ... York with offices in San Francisco, Dallas, ... dedicated to expanding possibilities for people with vision loss. ...
(Date:12/14/2009)... women,s hospital -- located within the C.S. Mott Children,s ... Jane Von Voigtlander ,, ANN ARBOR, Mich., Dec. ... has received a $15 million gift from the Ted ... made to the Health System for women,s health. It ... ,, The gift is being announced today in advance ...
(Date:12/14/2009)... the December issue of Mayo Clinic Proceedings , ... This retrospective study is the largest ever conducted in ... a serious disorder that disrupts the body,s normal production ... the bone marrow, leading to severe anemia, weakness, fatigue ... "In the past 20 years, management of primary myelofibrosis ...
Breaking Medicine News(10 mins):Health News:Scientists uncover protective mechanism against liver cancer 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4Health News:The American Foundation for the Blind Welcomes New Board Chair, Concetta F. Conkling 2Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 2Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 3Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 4Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 5
... of Dr. Michael McCarty, is now offering full service ... answer for those who need dental work and yet ... made it safe and comfortable for people to have ... a painful experience. Dr. Michael McCarty from Austin Smiles ...
... at the Stanford University School of ,Medicine have found ... of individual proteins in cells and living mammals, providing ... precisely than ever ,before the functions of different ... speed the development of therapies ,in which cancer-fighting proteins ...
... Over-55 bettors more likely to ask casinos to bar them, ... 28 (HealthDay News) -- Older problem gamblers who ask to ... likely than younger gambling addicts to do so because they,re ... to a new study. , The study included 1,601 ...
... Institutes of Health has awarded iCRco partner Vixar a Phase I SBIR ... images in computed radiography systems. Vixar is developing the new technology ... evaluate the potential of the technology for the digital x-ray imaging market. ... ...
... Sept. 27 Lung Cancer Alliance,President and CEO Laurie ... at Lung Cancer Alliance, our Board, our advocates and ... sympathy,to the wife and family of Paul Newman., ... and film, loved by,audiences around the world. He and ...
... surge in allergy and asthma problems after Hurricane Ike and provides ... ... Houston, TX (PRWEB) September 24, 2008--Although Hurricane Ike has already ... of this devastating hurricane has yet to be determined. It ...
Other Medicine News:Health News:Austin Dentistry Clinic Now Offers Certified Full Service Sedation Dentistry -- All Gain, No Pain 2Health News:New way to control protein activity could lead to cancer therapies 2Health News:New way to control protein activity could lead to cancer therapies 3Health News:Older Problem Gamblers Face Increased Suicide Risk 2Health News:NIH Awards a Phase I Small Business Innovative Research Grant on "Novel Laser Scanning Technology for Computed Radiography" to VIXAR and iCRco 2Health News:A Statement from Lung Cancer Alliance on the Death of Paul Newman 2Health News:Sudden Rise in Allergies and Asthma After Hurricane Ike 2Health News:Sudden Rise in Allergies and Asthma After Hurricane Ike 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: